Date Filed | Type | Description |
08/15/2023 |
4
| Huh Hoyoung (10% Owner) has filed a Form 4 on Peak Bio, Inc.
Txns:
| Exercised (in-or-at-the-money) 583,333 options to buy
@ $0.6, valued at
$350k
|
|
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2023 |
4
| Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
05/02/2023 |
4
| Huh Hoyoung (Director) has filed a Form 4 on Peak Bio, Inc.
Txns:
| Granted 1,884,625 options to buy
@ $0.6, valued at
$1.1M
Granted convertible notes
@ $1130775, valued at
$0 |
|
03/21/2023 |
SC 13D
| Huh Hoyoung reports a 40.2% stake in Peak Bio, Inc. |
11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/21/2022 |
4
| Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 15,000 options to buy
@ $6.8, valued at
$102k
|
|
06/30/2021 |
4
| Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
06/09/2020 |
4
| Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Converted 139,860 shares
@ $0 Converted 1,000,000 preferred shares
@ $0 |
|
06/02/2020 |
3
| Huh Hoyoung (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
06/22/2018 |
4
| Huh Hoyoung (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns:
| Granted 83,720 options to buy
@ $17, valued at
$1.4M
|
|
06/19/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/15/2018 |
4
| Huh Hoyoung (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 14,000 options to buy
@ $25.25, valued at
$353.5k
|
|
05/17/2018 |
4
| Huh Hoyoung (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 70,000 options to buy
@ $3.43, valued at
$240.1k
|
|
01/02/2018 |
4
| Huh Hoyoung (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 10,764 shares
@ $0 |
|
10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/22/2017 |
4
| Huh Hoyoung (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 14,000 options to buy
@ $13.78, valued at
$192.9k
|
|
05/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/18/2017 |
4
| Huh Hoyoung (Chairman, Scientific Adv. Bd.) has filed a Form 4 on AntriaBio, Inc. |
06/14/2016 |
4
| Huh Hoyoung (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 28,000 options to buy
@ $10.17, valued at
$284.8k
|
|
05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/01/2013 |
4
| Huh Hoyoung (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 5,784 shares
@ $0 |
|
05/24/2013 |
4
| Huh Hoyoung (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 35,000 options to buy
@ $1.1, valued at
$38.5k
|
|
02/08/2013 |
3
| Huh Hoyoung (10% Owner) has filed a Form 3 on AntriaBio, Inc. |
01/03/2013 |
4
| Huh Hoyoung (Director) has filed a Form 4 on GERON CORP
Txns:
| Disposed/sold 10,000 shares
@ $0 |
|
05/18/2012 |
4
| Huh Hoyoung (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 21,277 shares
@ $0 Granted 35,000 options to buy
@ $1.41, valued at
$49.4k
|
|
05/24/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/11/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/13/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/21/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
04/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|